Geode Capital Management LLC Increases Holdings in Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Geode Capital Management LLC grew its holdings in Stereotaxis, Inc. (NYSEAMERICAN:STXS) by 7.2% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 1,391,718 shares of the company’s stock after acquiring an additional 93,253 shares during the period. Geode Capital Management LLC’s holdings in Stereotaxis were worth $2,840,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of STXS. Jane Street Group LLC increased its position in shares of Stereotaxis by 26.9% during the third quarter. Jane Street Group LLC now owns 29,773 shares of the company’s stock valued at $61,000 after buying an additional 6,313 shares during the period. Charles Schwab Investment Management Inc. boosted its position in Stereotaxis by 10.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 167,297 shares of the company’s stock valued at $341,000 after acquiring an additional 15,491 shares in the last quarter. SG Americas Securities LLC purchased a new position in shares of Stereotaxis during the 3rd quarter worth approximately $39,000. State Street Corp raised its position in shares of Stereotaxis by 5.7% in the 3rd quarter. State Street Corp now owns 680,612 shares of the company’s stock worth $1,388,000 after acquiring an additional 36,518 shares in the last quarter. Finally, Rhumbline Advisers lifted its stake in shares of Stereotaxis by 645.6% in the 2nd quarter. Rhumbline Advisers now owns 48,251 shares of the company’s stock valued at $88,000 after purchasing an additional 41,780 shares during the period. Hedge funds and other institutional investors own 45.35% of the company’s stock.

Stereotaxis Stock Performance

NYSEAMERICAN STXS opened at $2.39 on Wednesday. The company has a market cap of $202.50 million, a P/E ratio of -8.54 and a beta of 1.57. Stereotaxis, Inc. has a twelve month low of $1.66 and a twelve month high of $3.29.

Stereotaxis (NYSEAMERICAN:STXS) last announced its earnings results on Monday, November 11th. The company reported ($0.08) EPS for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.03). The business had revenue of $9.20 million for the quarter, compared to the consensus estimate of $6.80 million. Stereotaxis had a negative net margin of 85.79% and a negative return on equity of 162.54%. Research analysts predict that Stereotaxis, Inc. will post -0.26 EPS for the current fiscal year.

About Stereotaxis

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.